April 2005
Media interview opportunity
The Asthma and Allergy Foundation of America (AAFA) available to comment on asthma study in the New England Journal of Medicine (NEJM)
Prominent asthma advocacy group available to provide perspective on study published in NEJM entitled "Daily Versus As-Needed Corticosteroids for Mild Persistent Asthma"
WHAT: New asthma findings suggest that some adults with mild persistent asthma may be able to adequately control their asthma by taking corticosteroids only when needed instead of taking anti-inflammatory medication daily
WHO: The Asthma and Allergy Foundation of America (AAFA), a not-for-profit organization, and is the leading patient organization for people with asthma and allergies - Spokesperson can discuss the following:
- Current guidelines recommend inhaled corticosteroids as safe, effective and preferred first-line therapy for children as well as adults with persistent asthma
- There is potential for confusion among patients and physicians as a result of the IMPACT study
- Patients should not discontinue any prescribed medications until advised by their physician
- The IMPACT study published in NEJM is preliminary
- Additional research needs to be conducted to confirm findings from the IMPACT study
- AAFA also can refer reporters to a physician for a clinical perspective on the IMPACT study